Cardiac-specific protein targeting domain
US-9249184-B2 · Feb 2, 2016 · US
Methods for treating myocardial infarction comprising administering sonic hedgehog
US9504732B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9504732-B2 |
| Application number | US-201414760494-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 14, 2014 |
| Priority date | Jan 14, 2013 |
| Publication date | Nov 29, 2016 |
| Grant date | Nov 29, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to methods and pharmaceutical compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, the present invention relates to a ligand of the sonic hedgehog signaling pathway for use in the cardioprotection of a subject who experienced a myocardial infarction.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for reducing infarct size and reperfusion arrhythmias in a patient in need thereof, said patient having had a myocardial infarction, comprising the steps of i) restoring blood supply in cardiac ischemic tissue of the patient, and ii) inducing cardioprotection by administering to the patient a therapeutically effective amount of a ligand of the sonic hedgehog signaling pathway, wherein the step of inducing cardioprotection causes a reductio…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9504732B2 cover?
- The present invention relates to methods and pharmaceutical compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, the present invention relates to a ligand of the sonic hedgehog signaling pathway for use in the cardioprotection of a subject who experienced a myocardial infarction.
- Who is the assignee on this patent?
- Inserm (Institut Nat De La Sante Et De La Rech Medicale), Univ Montpellier, Assist Publique-Hopitaux De Paris, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification A61K38/1709. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).